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Short telomere length is associated with impaired cognitive
performance in European ancestry cohorts
S Hägg1, Y Zhan1, R Karlsson1, L Gerritsen1, A Ploner1, SJ van der Lee2, L Broer3, J Deelen4,5, RE Marioni6,7,8, A Wong9, A Lundquist10,
G Zhu11, NK Hansell8,11, E Sillanpää12, IO Fedko13, NA Amin2, M Beekman4, AJM de Craen14,✠, S Degerman15, SE Harris6,7, K-J Kan13,
CM Martin-Ruiz16, GW Montgomery11, NeuroCHARGE Cognitive Working Group, AN Adolfsson17, CA Reynolds18, NJ Samani19,20,
HED Suchiman4, A Viljanen12, T von Zglinicki21, MJ Wright8,22, J-J Hottenga13, DI Boomsma13, T Rantanen12, JA Kaprio23,24,25,
DR Nyholt11,26, NG Martin11, L Nyberg27,28,29, R Adolfsson17, D Kuh9, JM Starr7,30, IJ Deary7,31, PE Slagboom4, CM van Duijn2, V Codd19,20,
NL Pedersen1 for the ENGAGE Consortium
The association between telomere length (TL) dynamics on cognitive performance over the life-course is not well understood. This
study meta-analyses observational and causal associations between TL and six cognitive traits, with stratiﬁcations on APOE
genotype, in a Mendelian Randomization (MR) framework. Twelve European cohorts (N= 17 052; mean age= 59.2 ± 8.8 years)
provided results for associations between qPCR-measured TL (T/S-ratio scale) and general cognitive function, mini-mental state
exam (MMSE), processing speed by digit symbol substitution test (DSST), visuospatial functioning, memory and executive
functioning (STROOP). In addition, a genetic risk score (GRS) for TL including seven known genetic variants for TL was calculated,
and used in associations with cognitive traits as outcomes in all cohorts. Observational analyses showed that longer telomeres were
associated with better scores on DSST (β= 0.051 per s.d.-increase of TL; 95% conﬁdence interval (CI): 0.024, 0.077; P= 0.0002), and
MMSE (β= 0.025; 95% CI: 0.002, 0.047; P= 0.03), and faster STROOP (β=− 0.053; 95% CI: − 0.087, − 0.018; P= 0.003). Effects for DSST
were stronger in APOE ε4 non-carriers (β= 0.081; 95% CI: 0.045, 0.117; P= 1.0 × 10− 5), whereas carriers performed better in STROOP
(β=− 0.074; 95% CI: − 0.140, − 0.009; P= 0.03). Causal associations were found for STROOP only (β=− 0.598 per s.d.-increase of TL;
95% CI: − 1.125, − 0.072; P= 0.026), with a larger effect in ε4-carriers (β=− 0.699; 95% CI: − 1.330, − 0.069; P= 0.03). Two-sample
replication analyses using CHARGE summary statistics showed causal effects between TL and general cognitive function and
DSST, but not with STROOP. In conclusion, we suggest causal effects from longer TL on better cognitive performance, where
APOE ε4-carriers might be at differential risk.
Translational Psychiatry (2017) 7, e1100; doi:10.1038/tp.2017.73; published online 18 April 2017
INTRODUCTION
Telomeres, short DNA sequences at the end of chromosomes, are
considered markers of biological age. Cell replication and
oxidative stressors contribute to the loss of telomere nucleotides
over time; below critical length, cellular senescence will follow.1
An increasing number of studies have shown the importance of
telomere length (TL) in ageing, speciﬁcally in the development of
dementia and cognitive impairment.2–8 Using a relatively large
group of non-demented older individuals, Yaffe et al.3 demon-
strated an association between longer telomeres and higher score
in the digit symbol substitution test (DSST)—a measure of
processing speed—at baseline. After seven years, the individuals
with longer telomeres at baseline performed better in the
modiﬁed mini-mental state exam (MMSE) but not in DSST.
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; 2Department of Epidemiology, Erasmus University Medical Center, Rotterdam,
The Netherlands; 3Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands; 4Department of Molecular Epidemiology, Leiden University
Medical Center, Leiden, The Netherlands; 5Max Planck Institute for Biology of Ageing, Cologne, Germany; 6Centre for Genomic and Experimental Medicine, Institute of Genetics
and Molecular Medicine, University of Edinburgh, Edinburgh, UK; 7Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK; 8Queensland
Brain Institute, University of Queensland, Brisbane, QLD, Australia; 9MRC Unit for Lifelong Health and Ageing at UCL, London, UK; 10Department of Statistics, Umeå University,
Umeå, Sweden; 11QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; 12Gerontology Research Center, Faculty of Sport and Health Sciences, University of
Jyväskylä, Jyväskylä, Finland; 13Department Biological Psychology, Vrije Universiteit, Amsterdam, The Netherlands; 14Department of Gerontology and Geriatrics, Leiden University
Medical Center, Leiden, The Netherlands; 15Department of Medical Biosciences, Umeå University, Umeå, Sweden; 16NIHR Newcastle Biomedical Research Centre & Unit, Institute
of Neurosciences, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK; 17Department of Clinical Sciences, Umeå University, Umeå, Sweden;
18Department of Psychology, University California Riverside, Riverside, CA, USA; 19Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; 20National Institute
for Health Research Leicester Cardiovascular Biomedical Research Unit, Glenﬁeld Hospital, Leicester, UK; 21Newcastle University Institute for Ageing, Institute for Cell & Molecular
Biosciences, Newcastle upon Tyne, UK; 22Centre for Advanced Imaging, University of Queensland, Brisbane, QLD, Australia; 23Department of Public Health, Clincum, University of
Helsinki, Helsinki, Finland; 24Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland; 25National Institute for Health and Welfare (THL), Helsinki,
Finland; 26Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia; 27Department of Radiation Sciences, Umeå University,
Umeå, Sweden; 28Department of Integrative Medical Biology (IMB), Umeå University, Umeå, Sweden; 29Umeå center for Functional Brain Imaging, Umeå University, Umeå,
Sweden; 30Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK and 31Department of Psychology, University of Edinburgh, Edinburgh, UK.
Correspondence: Dr S Hägg, Department of Medical Epidemiology and Biostatistics (MEB), Karolinska Institutet, Box 281, Stockholm 171 77, Sweden.
E-mail: Sara.hagg@ki.se
✠Deceased.
Received 13 February 2017; accepted 13 February 2017
Citation: Transl Psychiatry (2017) 7, e1100; doi:10.1038/tp.2017.73
www.nature.com/tp
Cohen-Manheim et al.8 investigated TL in young adults and found
faster attrition rates with poorer mid-life general- and domain-
speciﬁc cognitive performance but no association with baseline
TL. In addition, a cross-sectional study of non-demented
individuals concluded that APOE ε4-carriers had longer TL but
faster attrition rates indicating abnormal cell turnover.9 Other
studies have also shown associations between TL and cognition
with conﬂicting results or were underpowered.4,6,10,11 Hence, the
underlying mechanisms by which telomeres may be involved in
cognitive performance are complex, and larger efforts are needed
to elucidate this relationship. Moreover, it is still unclear whether
short telomeres are a cause, consequence or both for cognitive
impairment.
One way to predict a causal association is to conduct a
Mendelian Randomization (MR) study,12 in which genetic markers
are used as proxies for an exposure (TL), to investigate an un-
biased effect on an outcome (cognitive performance). Because
genetic variants are randomly assorted at meiosis, they are
generally free from conventional confounding and hence the MR
study design is often referred to as nature’s own clinical trial.13
We hypothesized that TL is an indicator of cellular stability,
which as such affects functioning throughout the body, including
performance on all types of cognitive traits.14 In addition,
individuals carrying the APOE ε4 allele are more susceptible to
cognitive impairment and are therefore of special interest.15 The
objective of our study was to conduct a meta-analytic MR study of
the association between TL and six cognitive traits in 12 European
ancestry cohorts (N= 17 052). A secondary aim was to stratify on
APOE ε4 genotype to investigate if carriers were at different risks
given their worse cognitive ability. Most cohorts were enrolled
through the European Network of Genomic and Genetic
Epidemiology (ENGAGE) Consortium. Telomere measurements
were performed by qPCR and a genetic risk score (GRS) with
seven genetic variants associated with TL16 was calculated.
Observational- as well as causal estimates were subsequently
obtained using an MR design.17 In a replication effort, summary
statistics from the Cohorts for Heart and Aging Research in
Genomic Epidemiology (CHARGE) Consortium for the genetic
associations with three cognitive traits18,19 were included in a two-
sample MR approach.20
MATERIALS AND METHODS
Study samples
Twelve cohorts with a total of 17 052 individuals (Table 1), all with
European ancestry populations, participated in the ENGAGE effort. The
sample-size weighted mean of age was 59.2 years with s.d. = 8.8. Most
cohorts contributed data measured at mid-life or older. The Leiden
Longevity Study 2 (LLS2) was the oldest cohort (mean age= 93.3 years).
The Netherlands Twin Register (NTR) included middle-aged adults (mean
age= 40.3 years, s.d. = 16.4) and QIMR (Twin studies at the Queensland
Institute of Medical Research) included adolescents only (mean age= 14.1
years, s.d. = 2.4). All but one study showed a fairly even proportion of sexes
(range: 49–67% women); FITSA (The Finnish Twin Study on Ageing)
included women only. Additional study-speciﬁc details are found in
Supplementary Table 1.
Cognitive traits
Six different cognitive traits were tested in a combined meta-analysis of
the ENGAGE cohorts: (1) general cognitive function; (2) MMSE; (3)
processing speed with DSST or the variant symbol digit substitution task;
(4) visuospatial functioning with block design test (BLOCK); (5) episodic
memory by either verbal learning or picture learning tests (MEMORY); and
(6) executive functioning using Stroop interference score (STROOP).
Detailed descriptions of the different cognitive traits are found in the
supplement (Supplementary Table 3). All cohorts participated with at least
one cognitive trait; no single cohort had all of them (Table 1).T
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Telomere length measurements
Telomere length was measured in leukocytes in whole blood/buffy coat
except for the HRS study, which used measurements from saliva. DNA from
saliva derives for the most part (~74%) from leukocytes,21 and TL
measurements from blood and saliva have been reported to have good
correlations (R= 0.72).22 Standard qPCR techniques for TL measurement
were applied as described by Cawthon23 with minor modiﬁcations in the
Lothian Birth Cohort (LBC)11 and BETULA.24 In brief, telomere (T) and single
copy gene (S) quantity were measured and a T/S-ratio was calculated. One
or several reference samples were included in all runs and a relative
telomere length was calculated for each sample.
Genotyping
Information on genotyping platform, quality control and single-nucleotide
polymorphisms (SNPs) used in each cohort is available in the supplement
(Supplementary Data and Supplementary Table 2). An additive un-
weighted GRS was calculated for each individual by summarizing the
number of risk alleles from seven different loci (TERC, TERT, NAF1, OBFC1,
ZNF208, RTEL1 and ACYP2) where SNPs (rs10936599, rs2736100, rs7675998,
rs9420907, rs8105767, rs755017 and rs11125529) have been found to
associate with TL.16 Investigations of possible pleiotropic effects from the
different genetic variants used in the GRS are discussed in the supplement
(Supplementary Data). Four cohorts (ERF (Erasmus Rucphen Family), LLS,
NTR and QIMR) from the current effort contributed to the original genome-
wide association study (GWAS) of TL (see Supplementary Data for further
discussions on implications to our study). No associations between any of
the seven TL genes and cognitive traits have been tested thus far as
judged from the GWAS Catalog.25 Genetic variants were prioritized as (1)
directly genotyped, (2) imputed with good quality, (3) proxies with r240.8
and (4) imputed from summary statistics. The weighted mean of the GRS
was 8.55 with s.d. = 1.51 (Table 1). APOE genotype was assessed separately
and available in most cohorts (Table 1).
Replication data
Summarized results from the CHARGE Consortium’s meta-analyses of
genome-wide association studies between genotypes and general
cognitive function (N= 53 949),18 processing speed by a meta-analysis of
four tests of processing speed including the DSST (N=32 088)19 and
executive functioning (STROOP; N=7726)19 were used to assess causal
associations from the same seven TL associated genetic variants.16 The
CHARGE cohorts were all of European ancestry and participants were aged
45 years or older. Some ENGAGE cohorts contributed to CHARGE analyses
of general cognitive function: BETULA1, ERF, HRS, and LBC1936; DSST and
STROOP: ERF; and DSST: LBC1936 (Table 1; see Supplementary Data for
further discussions on implications to our study). The general cognitive
function phenotype was created as a composite score of multiple cognitive
tests18 from principal component analysis. The processing speed variable
was created from DSST and three similar tests, and executive functioning
was assessed by either Trail Making tests or Stroop color and word
interference tests.19 Effect sizes were missing for DSST and STROOP; hence
results were presented in Z-scores only.
Statistical analyses
All variables (TL and cognitive traits) were Z-transformed with subtraction
of the mean and division of s.d. to enable comparisons across cohorts. Age
groups, instead of continuous age, were deﬁned and used as covariates to
allow for non-linear age effects: (1) 0–29 years; (2) 30–59 years; (3) 60–79
years; and (4) 80+ years. Cohorts with information on APOE genotype
performed additional analyses stratiﬁed on ε4-carriers (ε4/ε4 and ε4/ε3)
and non-carriers (ε3/ε3, ε2/ε3 and ε2/ε2). Individuals with the genotype ε2/
ε4 are excluded from the analysis. All models are described in detail in the
Supplementary Data; brieﬂy, all cohorts contributed with summary data
from three different models as depicted in Figure 1. Linear regressions
were ﬁtted for the associations of (1) TL on cognitive trait (TL-trait), (2) GRS
on TL (GRS-TL), and (3) GRS on cognitive trait (GRS-trait). All models were
adjusted for sex, age group and study-speciﬁc covariates. Effect estimates
from all models were pooled across cohorts via ﬁxed-effect meta-analysis,
except when evidence was found for statistically signiﬁcant heterogeneity
(P-valueo0.05), in which case a random-effects meta-analysis was
performed instead. Then, instrumental variable (IV) analysis was conducted
by calculating a Wald-type causal estimate for the effect of TL on each
cognitive trait (IV− trait =GRS− trait/GRS-TL). Effect differences between
observed (TL-trait) and causal/predicted (IV-trait) estimates were calculated
by subtracting the causal beta from the observational beta in a Z-test
(Supplementary Data). Stratiﬁed analyses on APOE genotype were done
similarly. For summary statistics data from CHARGE, a causal estimate was
calculated as described by Burgess et al.20 (Supplementary Data). Crude
P-values are presented for all associations, that is, no multiple testing
corrections have been applied.
RESULTS
Observational analyses of telomere length and cognitive traits
Signiﬁcant associations, supporting the relationship between
longer telomeres and better cognitive ability, were seen between
TL and MMSE, DSST and STROOP using ﬁxed-effects meta-analysis
(Table 2, Figure 2). Positive associations were observed for MMSE
(0.025 per s.d.-increase in TL; 95% conﬁdence interval (CI) 0.002,
0.047) and DSST (0.051; 95% CI 0.024, 0.077). For STROOP, a
negative beta (−0.053 per s.d.-increase in TL; 95% CI − 0.087,
− 0.018) was seen, which was in accordance with the hypothesis
that longer telomeres are associated with shorter time for
completion of the Stroop interference test. However, after
corrections for multiple comparisons, the association with MMSE
was not signiﬁcant.
Genetic risk score for telomere length
The combined effect of the GRS on TL was − 0.048 s.d.− change of
TL per allele (95% CI: − 0.064, − 0.032, P-value = 4.0*10− 9)
calculated using random-effects meta-analysis (Supplementary
Data: Supplementary Figure S1). The corresponding F-statistic was
36, indicating that the GRS-TL estimate provided a sufﬁciently
strong instrument for further use in IV analyses.26 Although
heterogeneity was detected, all cohorts showed negative effect
sizes ranging from − 0.01 to − 0.13 (Supplementary Table S1).
Additional tests investigating possible pleiotropic effects for SNP-
trait associations were done and found no evidence of such
(Supplementary Data).
Instrumental variable analyses of telomere length and cognitive
traits
Instrumental variable analyses for causal associations of TL on
cognitive performance were conducted for all cognitive traits.
Only the association between TL and STROOP was found to be
causal (Table 2), and for each s.d.-decrease in TL an effect change
of − 0.60 in Stroop score was detected (95% CI: − 1.12, − 0.07,
P-value = 0.026). However, the association would not be signiﬁcant
Figure 1. Graph describing the design of the study. A genetic risk
score (GRS) for telomere length (TL) is used in the instrumental
variable (IV) analysis to determine the predicted effect of TL on
different cognitive traits (IV-trait). The Mendelian Randomization
design allows for calculation of an estimate independent of
confounders (C) in comparison to the observed effect estimated
between TL and cognitive traits (TL-trait).
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after multiple testing adjustments. The difference in effect sizes
between observational and causal betas for STROOP was
statistically signiﬁcant (Table 2).
Stratiﬁed analyses
Stratiﬁed meta-analyses were performed for APOE ε4-carriers
(n⩽ 2380) and ε4 non-carriers (n⩽5669) separately (Supplementary
Data). Observational associations were seen between TL and DSST
in non-carriers (β= 0.081, 95% CI: 0.045, 0.117, P-value = 1 × 10− 5)
and with better performance for STROOP in carriers (β=− 0.074,
95% CI: − 0.140, − 0.009, P-value = 0.027) (Supplementary Table
S4). A causal association between long telomeres and better
performance for STROOP was detected amongst APOE ε4-carriers
(β=− 0.70, 95% CI: − 1.33, − 0.07, P-value = 0.030), although the
ﬁnding would not hold after multiple testing adjustments. No
other causal effects for TL on cognitive traits were seen in either
carriers or non-carriers (Supplementary Table S6).
Replication analyses
In replication efforts, two-sample MR analyses were carried out using
summary statistics from CHARGE GWAS on general cognitive
function, DSST and STROOP. Data from the TL GWAS were used for
the genetic instrument (Supplementary Data). Results provided
evidence for a causal association between longer leukocyte TL and
better general cognitive function (β= 0.086 per s.d.-increase of TL,
95% CI: 0.016–0.156, P-value = 0.016, Table 2) and better DSST
Table 2. Associations between predicted and observed telomere length and different cognitive traits
Cognitive trait ENGAGEa CHARGE
Predicted effect (IV-trait) Predicted effect (IV-trait)
N Beta (95% CI) P-value N Beta (95% CI) P-value
MMSE 7066 0.291 (−0.05, 0.631) 0.095
DSST 4419 − 0.016 (−0.437, 0.405) 0.941 32 088 2.021b 0.043
BLOCK 5001 − 0.192 (−0.594, 0.21) 0.349
MEMORY 13 060 − 0.022 (−0.264, 0.22) 0.860
STROOP 2940 − 0.598 (−1.125, − 0.072) 0.026 7726 − 0.780b 0.435
General 12 283 0.039 (−0.229, 0.306) 0.778 53 949 0.086 (0.016, 0.156) 0.016
Cognitive trait Observed effect (TL-trait)
Diff-P-value Beta (95% CI) P-value
MMSE 0.13 0.025 (0.002, 0.047) 0.030
DSST 0.76 0.051 (0.024, 0.077) 0.0002
BLOCK 0.34 0.004 (−0.024, 0.032) 0.781
MEMORY 0.79 0.011 (−0.005, 0.028) 0.187
STROOP 0.04 − 0.053 (−0.087, −0.018) 0.003
General 0.89 0.020 (−0.008, 0.047) 0.156
Abbreviations: BLOCK, Block-design test; CI, conﬁdence interval; Diff-P-value, tests for difference in estimators between observed and predicted effects; DSST,
Digit-symbol substitution test; General, General cognitive performance; IV, instrumental variable; MEMORY, Verbal memory or Picture learning test; MMSE,
Mini-mental state exam; STROOP, Stroop color word task interference score; TL, telomere length. aAll models are adjusted for age group and sex. No
adjustments for multiple testing have been done on the reported P-values. bZ-scores, effect sizes are missing.
Figure 2. Observed effects between telomere length and cognitive traits. Fixed-effects meta-analyses were performed across cohorts and
domains for all cognitive traits. Signiﬁcant effects (s.d.-change in cognitive score for an s.d.-change in telomere length (TL)) were found for (a).
digit symbol substitution test tapping processing speed (DSST), (b). Mini-mental state exam (MMSE), and (c). Stroop interference score tapping
executive functioning (STROOP). All models were adjusted for age group, sex and study-speciﬁc covariates.
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scoring (Z-score = 2.02, P-value = 0.043, Table 2). No evidence for a
causal effect by TL on STROOP was found (Table 2).
DISCUSSION
In the present study, we provide evidence for observational and
causal associations between longer telomeres and better cogni-
tive performance. By conducting a large meta-analysis of 12
cohorts from European ancestry populations with measured
telomeres and assessments of cognitive function, we were able
to observe associations between TL and better scoring on MMSE,
DSST and STROOP. Moreover, APOE ε4-carriers seemed to have
different effects for the observed association with worse
performance in DSST but better in STROOP. The association
between longer telomeres and faster completion of the Stroop
interference test was also found to be signiﬁcant in causal analysis
for all individuals and in APOE ε4-carriers only. However, none of
the signiﬁcant causal associations detected for STROOP passed
multiple testing corrections. Hence, in line with this, using
summary data from CHARGE, we found support for a causal
association from TL on general cognitive function and DSST, but
not on STROOP.
In the biology of aging, telomere length has long been
considered as a biomarker reﬂecting the underlying cellular state.
Recently, however, several research papers have presented
evidence of telomeres being involved in the process of cellular
senescence causing increased risk of disease.5,16,27 Moreover,
other studies suggest telomeres might even elongate in somatic
cells to maintain cellular stability,21,28,29 although this phenom-
enon could be partly explained by leukocyte turnover or imprecise
measurements. Nevertheless, telomere biology has implications
for the aging processes and studies are warranted to elucidate the
full complexity.
With this effort we demonstrate several observational associa-
tions between TL and cognitive traits, both conﬁrming earlier
studies and presenting new links. General cognitive function is
usually operationalized as a composite score across a number of
diverse cognitive domains capturing most of the cognitive
variation.18 As an overall measure of cognition it also predicts
mortality;30 likewise, the length of telomeres can be used to
predict mortality.31,32 Thus, if both general cognitive function and
TL serve as valid biomarkers of aging, associations between these
markers are expected, although causality needs to be further
investigated. In the ENGAGE data (N= 12 283), we were not able to
detect any association between general cognitive function and TL,
but using the CHARGE summary data (N= 53 949) we provided
evidence for a causal association. It is likely that the ENGAGE
analysis was low in power; effect sizes had overlapping CI’s. A
possible biological mechanism for a causal association could be
explained by overall body frailty; the lengths of telomeres are
important for maintaining cellular stability at old age and hence
also important for biological aging processes such as decline in
cognitive performance.1 Causal links have also been demonstrated
using animal models. A mouse with telomerase deﬁciency,
expressing accelerated aging with malfunctioning tissue repair
and impaired neurological function, had restored functions again
upon telomerase reactivation.33
The DSST test assesses processing speed required to translate a
code of symbols and digits as fast as possible in a given time
frame. Processing speed has been demonstrated to have a steady,
almost linear decline with advancing age, and its decline leads
other forms of cognitive decline.34,35 Hence, in light of this it is not
surprising that we, and others,3 detect a fairly stable observational
association of longer telomeres and better DSST scoring. The MR
analysis did not indicate a causal association in our samples
(N= 4419); on the other hand, when increasing power using
CHARGE data (N= 32 088) we were able to ﬁnd support for a
positive causal relationship from longer TL on DSST scoring.
Moreover, APOE ε4 non-carriers scored better on the test with a
larger effect size seen in observational analysis from TL on DSST.
Thus, as APOE genotype is important for elucidating different risk
groups for many age-related phenotypes, it is possible that it
applies to TL dynamics and cognitive performance as well.
Yaffe et al.3 showed that longer TL at baseline gave less
longitudinal decline in MMSE, and we presented cross-sectional
evidence from observational associations in line with these
ﬁndings; longer TL is consistent with better MMSE scoring.
However, while causal estimates support these associations, the
CI´s were wide and results did not reach statistical signiﬁcance.
Unfortunately, CHARGE data on MMSE were not available for
replication analysis.
The STROOP variable taps the executive functioning by a
combined color and word test to be completed as quickly as
possible. To the best of our knowledge, there has been only one
earlier small study investigating baseline and attrition TL
associations with executive functioning, with inconclusive
results.8 Our ENGAGE analysis included 2940 individuals where
we found both an observational and causal association between
longer telomeres and faster completion of the Stroop test. The
large effect size difference was however disturbing and not
explained by additional adjustments for smoking and alcohol
(Supplementary Data). Further, causal associations did not hold
after multiple testing corrections and when using the two-sample
approach including the larger CHARGE data (N= 7726) we could
not replicate the association, although the effects were in the
same direction. Hence, it is possible that the STROOP ﬁnding
observed in the ENGAGE data is a false discovery. In addition, the
stratiﬁed analyses by APOE ε4 genotype found ε4-carriers to
perform better, which is contradictory to what would be expected.
The strength of this study is the effort of combining multiple
European cohorts with TL, cognitive and genetic data available as
well as APOE genotype. By doing so, we were able to detect
patterns of associations for different cognitive traits that would
not be possible to ﬁnd in single study analyses. Moreover, we
included large-scale CHARGE GWAS data sets to perform two-
sample MR analyses as replication. The weaknesses of the study
include generalizability, as the analyses were performed solely in
European ancestry populations, and some of the cohorts were
included in both ENGAGE and CHARGE analyses as described in
the supplement. Moreover, heterogeneity due to different tissues
used (blood and saliva) and lab-speciﬁc technical variances (TL
estimates from all 12 cohorts were done in ﬁve different labs) may
have driven the results toward null. Another limitation relates to
the three assumptions for conducting MR studies, which have
been considered as follows: (1) a strong genetic instrument should
be demonstrated between the GRS and TL (GRS-TL) which we
have (F-statistic = 36); (2) the genetic instrument should not be
confounded by e.g., age and sex (unlikely considering the
randomization of alleles at conception); and (3) pleiotropic effects
(when other pathways exist from the TL SNPs to the outcome
(cognitive trait) without going through the intermediate pheno-
type (TL)) from the SNPs included in the GRS should be ruled out
as much as possible. We did not ﬁnd evidence for pleiotropic
effects (Supplementary Data). Finally, also worth mentioning are
the relatively weak P-values for some of the associations. The
observational association for MMSE would not hold after
Bonferroni correction of the P-value for the six cognitive traits
tested, likewise for the causal associations found for STROOP.
To conclude, this study demonstrates an overall picture of the
importance of biological aging processes such as TL dynamics for
maintaining cognitive function throughout life. More speciﬁcally,
we were able to show observational as well as causal associations
between TL and different cognitive traits that have never been
elucidated before. Hence, the current effort presents new
important pieces of evidence for the continued search for a
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better understanding of the biology behind aging and the factors
explaining healthy aging.
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